These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 14693304

  • 21. A retrospective cohort study to assess the impact of therapeutic substitution of darbepoetin alfa for epoetin alfa in anemic patients with myelodysplastic syndrome.
    Patton JF, Sullivan T, Mun Y, Reeves T, Rossi G, Wallace JF.
    J Support Oncol; 2005; 3(6):419-26. PubMed ID: 16350429
    [Abstract] [Full Text] [Related]

  • 22. [Study of effectiveness of 3 schedules of administration of erythropoietic colony-stimulating factors in anemic patients under chemotherapy for solid or hematology malignancy].
    Pontón Sivillá JL, Feliu Frasnedo E, Modamio Charles P, Mariño Hernández EL, Font Pous A, Lezcano Rubio C, Ribera Santasusana JM, Bonafont Pujol X.
    Med Clin (Barc); 2008 Oct 11; 131(12):447-51. PubMed ID: 18928734
    [Abstract] [Full Text] [Related]

  • 23. Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.
    Voils SA, Harpe SH, Brophy GM.
    Pharmacotherapy; 2007 Apr 11; 27(4):535-41. PubMed ID: 17381380
    [Abstract] [Full Text] [Related]

  • 24. Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease.
    Chen HH, Tarng DC, Lee KF, Wu CY, Chen YC.
    J Nephrol; 2008 Apr 11; 21(4):543-9. PubMed ID: 18651544
    [Abstract] [Full Text] [Related]

  • 25. Conversion from epoetin alfa to darbepoetin alfa for management of anaemia in a community chronic kidney disease centre: a retrospective cohort study.
    Gobin J, Cernii A, McLean R, Finkelstein FO, Simon DB.
    Clin Drug Investig; 2011 Apr 11; 31(2):113-20. PubMed ID: 21067252
    [Abstract] [Full Text] [Related]

  • 26. Extended-dosage-interval regimens of erythropoietic agents in chemotherapy-induced anemia.
    Muller RJ, Baribeault D.
    Am J Health Syst Pharm; 2007 Dec 15; 64(24):2547-56. PubMed ID: 18056942
    [Abstract] [Full Text] [Related]

  • 27. A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit.
    Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P, ASSESS Study Group and Amgen Inc.
    Clin Ther; 2008 Dec 15; 30(12):2324-34. PubMed ID: 19167591
    [Abstract] [Full Text] [Related]

  • 28. A randomized, open-label, multicenter trial of immediate versus delayed intervention with darbepoetin alfa for chemotherapy-induced anemia.
    Charu V, Saidman B, Ben-Jacob A, Justice GR, Maniam AS, Tomita D, Rossi G, Rearden T, Glaspy J.
    Oncologist; 2007 Oct 15; 12(10):1253-63. PubMed ID: 17962619
    [Abstract] [Full Text] [Related]

  • 29. Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies.
    Henry DH.
    Drugs; 2007 Oct 15; 67(2):175-94. PubMed ID: 17284083
    [Abstract] [Full Text] [Related]

  • 30. Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy.
    Cortesi E, Mancuso A, De Pasquale Ceratti A, Pizzardi N, D'Auria G, Accettura C, Beccaglia P, Bertelletti D, De Marinis F.
    Oncologist; 2004 Oct 15; 9(4):459-68. PubMed ID: 15266099
    [Abstract] [Full Text] [Related]

  • 31. The impact of methodological approach on cost findings in comparison of epoetin alfa with darbepoetin alfa.
    Song X, Long SR, Marder WD, Sullivan SD, Kallich J.
    Ann Pharmacother; 2009 Jul 15; 43(7):1203-10. PubMed ID: 19584392
    [Abstract] [Full Text] [Related]

  • 32. Optimizing the dose and schedule of darbepoetin alfa in patients with chemotherapy-induced anemia.
    Glaspy J.
    Oncology (Williston Park); 2006 Jul 15; 20(8 Suppl 6):29-32. PubMed ID: 16925109
    [Abstract] [Full Text] [Related]

  • 33. Impact of long-acting growth factors on practice dynamics and patient satisfaction.
    Beveridge RA, Rifkin RM, Moleski RJ, Milkovich G, Reitan JF, Paivanas TA, Jacobs RJ.
    Pharmacotherapy; 2003 Dec 15; 23(12 Pt 2):101S-109S. PubMed ID: 14694999
    [Abstract] [Full Text] [Related]

  • 34. Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia.
    Boccia R, Malik IA, Raja V, Kahanic S, Liu R, Lillie T, Tomita D, Clowney B, Silberstein P.
    Oncologist; 2006 Apr 15; 11(4):409-17. PubMed ID: 16614237
    [Abstract] [Full Text] [Related]

  • 35. Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients.
    Nissenson AR, Swan SK, Lindberg JS, Soroka SD, Beatey R, Wang C, Picarello N, McDermott-Vitak A, Maroni BJ.
    Am J Kidney Dis; 2002 Jul 15; 40(1):110-8. PubMed ID: 12087568
    [Abstract] [Full Text] [Related]

  • 36. Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia.
    Hernandez E, Ganly P, Charu V, Dibenedetto J, Tomita D, Lillie T, Taylor K, ARANESP 20030232 Study Group.
    Curr Med Res Opin; 2009 Sep 15; 25(9):2109-20. PubMed ID: 19601709
    [Abstract] [Full Text] [Related]

  • 37. An open-label, randomized, multicenter, controlled study of epoetin alfa for the treatment of anemia of chronic kidney disease in the long term care setting.
    Patel M, Thimons DG, Winston JL, Langholff W, McGowan T.
    J Am Med Dir Assoc; 2012 Mar 15; 13(3):244-8. PubMed ID: 21450214
    [Abstract] [Full Text] [Related]

  • 38. Preference for monthly darbepoetin alfa dosing in patients with chronic kidney disease not receiving dialysis.
    Hoggard J, Crouch T, McMurray S, Levine M, Prathikanti R, Scarlata D, Audhya P.
    Curr Med Res Opin; 2006 Oct 15; 22(10):2023-30. PubMed ID: 17022861
    [Abstract] [Full Text] [Related]

  • 39. Dose and cost comparison of erythropoietic agents in the inpatient hospital setting.
    Vekeman F, McKenzie RS, Lefebvre P, Watson SH, Mody SH, Piech CT, Duh MS.
    Am J Health Syst Pharm; 2007 Sep 15; 64(18):1943-9. PubMed ID: 17823106
    [Abstract] [Full Text] [Related]

  • 40. Guidelines for using darbepoetin alfa in patients with chemotherapy-induced anemia.
    Bloomfield M, Jaresko G, Zarek J, Dozier N.
    Pharmacotherapy; 2003 Dec 15; 23(12 Pt 2):110S-118S. PubMed ID: 14695000
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.